Ken Research Logo

US animal health market report Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

The US Animal Health Market, valued at USD 19 billion, is growing due to increased pet ownership, advancements in veterinary medicine, and rising demand for animal health products like pharmaceuticals and vaccines.

Region:North America

Author(s):Dev

Product Code:KRAC4854

Pages:88

Published On:October 2025

About the Report

Base Year 2024

US Animal Health Market Overview

  • The US Animal Health Market is valued at USD 19 billion, based on a five-year historical analysis. This growth is primarily driven by increasing pet ownership, rising awareness of animal health, and advancements in veterinary medicine. The demand for pharmaceuticals, vaccines, and diagnostics has surged as pet owners and livestock farmers prioritize animal welfare and preventive care. Recent trends include the growing adoption of companion animals by millennials, rising livestock production, and heightened concerns about food-borne and zoonotic diseases, which are further accelerating market expansion.
  • Key players in this market include major cities such as New York, Los Angeles, and Chicago, which dominate due to their large populations and high disposable incomes. Additionally, states with significant agricultural activities, like Texas and California, contribute to the market's growth by emphasizing livestock health and productivity. The market also benefits from regional diversity, with urban centers driving companion animal healthcare and rural/agricultural states supporting production animal health.
  • In 2023, the US government implemented the Animal Drug User Fee Amendments (ADUFA), which aims to expedite the approval process for animal drugs. The Animal Drug User Fee Amendments of 2023, issued by the US Food and Drug Administration, require manufacturers to pay user fees for the review and approval of new animal drugs, thereby enhancing the efficiency and timeliness of bringing new veterinary products to market. This regulation covers prescription and generic animal drugs, sets specific fee schedules, and mandates compliance with FDA review standards.
US Animal Health Market Size

US Animal Health Market Segmentation

By Type:The market is segmented into various types, including Pharmaceuticals, Vaccines, Medicinal Feed Additives, Diagnostics, Biologics, Equipment & Disposables, and Others. Among these, Pharmaceuticals and Vaccines are the leading segments due to their critical role in disease prevention and treatment in both companion and production animals. The increasing prevalence of zoonotic diseases and the growing trend of preventive healthcare are driving the demand for these products. Pharmaceuticals account for the largest share, reflecting strong demand for parasiticides, antibiotics, and pain management products, while vaccines continue to grow due to their importance in preventive care and outbreak control.

US Animal Health Market segmentation by Type.

By End-User:The end-user segmentation includes Veterinary Hospitals & Clinics, Veterinary Reference Laboratories, Point-of-Care/In-House Testing, Livestock Farmers, and Pet Owners. Veterinary Hospitals & Clinics dominate this segment as they are the primary providers of animal healthcare services, driving the demand for various health products and services. The increasing number of pet owners and livestock farmers seeking professional veterinary care further supports this trend. Veterinary Hospitals & Clinics account for the largest share, reflecting their central role in both companion and production animal health management.

US Animal Health Market segmentation by End-User.

US Animal Health Market Competitive Landscape

The US Animal Health Market is characterized by a dynamic mix of regional and international players. Leading participants such as Zoetis Inc., Merck Animal Health, Elanco Animal Health, Boehringer Ingelheim Animal Health, Ceva Santé Animale, Virbac Corporation, IDEXX Laboratories, Inc., Neogen Corporation, Phibro Animal Health Corporation, Vetoquinol USA, Covetrus, Inc., PetIQ, Inc., VetCor, Trupanion, Inc., PetSmart, Inc. contribute to innovation, geographic expansion, and service delivery in this space.

Zoetis Inc.

1952

Parsippany, New Jersey, USA

Merck Animal Health

1891

Kenilworth, New Jersey, USA

Elanco Animal Health

1954

Greenfield, Indiana, USA

Boehringer Ingelheim Animal Health

1885

Ingelheim am Rhein, Germany

Ceva Santé Animale

1999

Libourne, France

Company

Establishment Year

Headquarters

Group Size (Large, Medium, or Small as per industry convention)

Revenue Growth Rate

Market Penetration Rate

Customer Retention Rate

Pricing Strategy

Product Portfolio Breadth

US Animal Health Market Industry Analysis

Growth Drivers

  • Increasing Pet Ownership:The American Pet Products Association reported that approximately 70% of U.S. households own a pet, translating to around 90 million homes. This surge in pet ownership has led to increased spending on veterinary services, with the American Veterinary Medical Association estimating that pet owners spent over $34 billion on veterinary care in the future. This trend is expected to continue, driving demand for animal health products and services as pet owners prioritize their pets' health and well-being.
  • Rising Demand for Animal Protein:The U.S. Department of Agriculture projected that meat production in the U.S. would reach approximately 102 billion pounds in the future, driven by a growing population and increasing protein consumption. This demand for animal protein necessitates enhanced animal health measures to ensure livestock productivity and disease prevention. Consequently, investments in veterinary services and animal health products are expected to rise, supporting the overall growth of the animal health market.
  • Advancements in Veterinary Medicine:The veterinary medicine sector is experiencing rapid advancements, with the market for veterinary pharmaceuticals expected to exceed $12 billion in the future. Innovations such as biologics, advanced diagnostics, and telemedicine are enhancing treatment options for animals. The integration of technology in veterinary practices is improving efficiency and outcomes, leading to increased adoption of veterinary services and products, thereby driving market growth in the animal health sector.

Market Challenges

  • High Cost of Veterinary Services:The cost of veterinary care has been rising significantly, with average expenditures per pet reaching approximately $1,600 annually in the future. This financial burden can deter pet owners from seeking necessary medical care for their animals, potentially leading to untreated health issues. As a result, the high cost of veterinary services poses a significant challenge to the growth of the animal health market, particularly among low-income households.
  • Stringent Regulatory Environment:The animal health industry is subject to rigorous regulations from agencies such as the FDA and USDA, which can complicate the approval process for new products. In the future, the FDA processed over 1,200 new animal drug applications, reflecting the stringent oversight in place. These regulatory hurdles can delay product launches and increase costs for companies, ultimately impacting their ability to compete effectively in the market.

US Animal Health Market Future Outlook

The future of the U.S. animal health market appears promising, driven by ongoing trends in pet ownership and advancements in veterinary care. As consumers increasingly prioritize preventive healthcare for their pets, the demand for innovative health solutions is expected to rise. Additionally, the integration of technology in veterinary practices will likely enhance service delivery, making veterinary care more accessible and efficient. These trends indicate a robust growth trajectory for the animal health sector in the coming years.

Market Opportunities

  • Expansion of Telemedicine in Veterinary Care:The rise of telemedicine offers significant opportunities for the animal health market, with a projected increase in virtual consultations expected to reach 25 million in the future. This trend allows pet owners to access veterinary care conveniently, particularly in underserved areas, thereby expanding the market reach and improving overall animal health outcomes.
  • Growth in E-commerce for Pet Products:E-commerce sales of pet products are anticipated to exceed $35 billion in the future, driven by changing consumer preferences for online shopping. This shift presents a lucrative opportunity for animal health companies to enhance their distribution channels and reach a broader audience, ultimately boosting sales of veterinary products and services.

Scope of the Report

SegmentSub-Segments
By Type

Pharmaceuticals

Vaccines

Medicinal Feed Additives

Diagnostics

Biologics

Equipment & Disposables

Others

By End-User

Veterinary Hospitals & Clinics

Veterinary Reference Laboratories

Point-of-Care/In-House Testing

Livestock Farmers

Pet Owners

By Distribution Channel

Hospital/Clinic Pharmacy

Retail

E-Commerce

Direct Sales

By Product Formulation

Injectable

Oral

Topical

By Animal Type

Companion Animals (Dogs, Cats, Horses, Others)

Production Animals (Cattle, Swine, Poultry, Sheep & Goats, Fish)

Aquaculture

By Price Range

Premium

Mid-Range

Economy

By Application

Preventive Care

Treatment of Diseases

Diagnostic Testing

Surgical Procedures

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., U.S. Department of Agriculture, Food and Drug Administration)

Manufacturers and Producers

Distributors and Retailers

Veterinary Clinics and Hospitals

Animal Health Product Wholesalers

Industry Associations (e.g., American Veterinary Medical Association)

Pharmaceutical Companies

Players Mentioned in the Report:

Zoetis Inc.

Merck Animal Health

Elanco Animal Health

Boehringer Ingelheim Animal Health

Ceva Sante Animale

Virbac Corporation

IDEXX Laboratories, Inc.

Neogen Corporation

Phibro Animal Health Corporation

Vetoquinol USA

Covetrus, Inc.

PetIQ, Inc.

VetCor

Trupanion, Inc.

PetSmart, Inc.

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. US Animal Health Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 US Animal Health Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. US Animal Health Market Analysis

3.1 Growth Drivers

3.1.1 Increasing Pet Ownership
3.1.2 Rising Demand for Animal Protein
3.1.3 Advancements in Veterinary Medicine
3.1.4 Growing Awareness of Animal Health

3.2 Market Challenges

3.2.1 High Cost of Veterinary Services
3.2.2 Stringent Regulatory Environment
3.2.3 Competition from Generic Products
3.2.4 Limited Access to Veterinary Care in Rural Areas

3.3 Market Opportunities

3.3.1 Expansion of Telemedicine in Veterinary Care
3.3.2 Growth in E-commerce for Pet Products
3.3.3 Increasing Investment in Animal Health Startups
3.3.4 Development of Personalized Animal Health Solutions

3.4 Market Trends

3.4.1 Shift Towards Preventive Healthcare
3.4.2 Integration of Technology in Animal Health
3.4.3 Rise of Organic and Natural Animal Products
3.4.4 Focus on Sustainability in Animal Farming

3.5 Government Regulation

3.5.1 FDA Regulations on Animal Drugs
3.5.2 USDA Guidelines for Animal Welfare
3.5.3 State-Level Veterinary Practice Acts
3.5.4 Environmental Regulations Impacting Animal Farming

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. US Animal Health Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. US Animal Health Market Segmentation

8.1 By Type

8.1.1 Pharmaceuticals
8.1.2 Vaccines
8.1.3 Medicinal Feed Additives
8.1.4 Diagnostics
8.1.5 Biologics
8.1.6 Equipment & Disposables
8.1.7 Others

8.2 By End-User

8.2.1 Veterinary Hospitals & Clinics
8.2.2 Veterinary Reference Laboratories
8.2.3 Point-of-Care/In-House Testing
8.2.4 Livestock Farmers
8.2.5 Pet Owners

8.3 By Distribution Channel

8.3.1 Hospital/Clinic Pharmacy
8.3.2 Retail
8.3.3 E-Commerce
8.3.4 Direct Sales

8.4 By Product Formulation

8.4.1 Injectable
8.4.2 Oral
8.4.3 Topical

8.5 By Animal Type

8.5.1 Companion Animals (Dogs, Cats, Horses, Others)
8.5.2 Production Animals (Cattle, Swine, Poultry, Sheep & Goats, Fish)
8.5.3 Aquaculture

8.6 By Price Range

8.6.1 Premium
8.6.2 Mid-Range
8.6.3 Economy

8.7 By Application

8.7.1 Preventive Care
8.7.2 Treatment of Diseases
8.7.3 Diagnostic Testing
8.7.4 Surgical Procedures

9. US Animal Health Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Group Size (Large, Medium, or Small as per industry convention)
9.2.3 Revenue Growth Rate
9.2.4 Market Penetration Rate
9.2.5 Customer Retention Rate
9.2.6 Pricing Strategy
9.2.7 Product Portfolio Breadth
9.2.8 R&D Investment as % of Revenue
9.2.9 Regulatory Approval Success Rate
9.2.10 Distribution Network Coverage
9.2.11 Brand Recognition Index
9.2.12 Innovation Pipeline Strength

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Zoetis Inc.
9.5.2 Merck Animal Health
9.5.3 Elanco Animal Health
9.5.4 Boehringer Ingelheim Animal Health
9.5.5 Ceva Santé Animale
9.5.6 Virbac Corporation
9.5.7 IDEXX Laboratories, Inc.
9.5.8 Neogen Corporation
9.5.9 Phibro Animal Health Corporation
9.5.10 Vetoquinol USA
9.5.11 Covetrus, Inc.
9.5.12 PetIQ, Inc.
9.5.13 VetCor
9.5.14 Trupanion, Inc.
9.5.15 PetSmart, Inc.

10. US Animal Health Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Budget Allocation for Animal Health
10.1.2 Decision-Making Processes
10.1.3 Preferred Suppliers
10.1.4 Compliance Requirements

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Veterinary Facilities
10.2.2 Spending on Animal Health Technologies
10.2.3 Budget for Research and Development

10.3 Pain Point Analysis by End-User Category

10.3.1 Access to Veterinary Services
10.3.2 Cost of Animal Health Products
10.3.3 Quality of Care

10.4 User Readiness for Adoption

10.4.1 Awareness of New Technologies
10.4.2 Training and Support Needs
10.4.3 Financial Readiness

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of Health Outcomes
10.5.2 Cost Savings Analysis
10.5.3 Expansion into New Services

11. US Animal Health Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Value Proposition Development

1.3 Revenue Streams Analysis

1.4 Cost Structure Evaluation

1.5 Key Partnerships Exploration

1.6 Customer Segmentation

1.7 Channels of Distribution


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs

2.3 Target Audience Identification

2.4 Communication Strategies

2.5 Digital Marketing Approaches


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-Ups

3.3 E-commerce Integration

3.4 Direct Sales Approaches


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands Analysis

4.3 Competitor Pricing Strategies


5. Unmet Demand & Latent Needs

5.1 Category Gaps Identification

5.2 Consumer Segments Analysis

5.3 Emerging Trends Exploration


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-Sales Service

6.3 Customer Feedback Mechanisms


7. Value Proposition

7.1 Sustainability Initiatives

7.2 Integrated Supply Chains

7.3 Customer-Centric Innovations


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding Efforts

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix Considerations
9.1.2 Pricing Band Strategy
9.1.3 Packaging Innovations

9.2 Export Entry Strategy

9.2.1 Target Countries Identification
9.2.2 Compliance Roadmap Development

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model Evaluation


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines for Implementation


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-Term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Activity Planning
15.2.2 Milestone Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of industry reports from veterinary associations and animal health organizations
  • Review of market data from government publications and agricultural departments
  • Examination of academic journals and white papers on animal health trends and innovations

Primary Research

  • Interviews with veterinarians and animal health practitioners to gather insights on market needs
  • Surveys with pet owners and livestock farmers to understand purchasing behaviors
  • Focus groups with industry experts to discuss emerging trends and challenges in animal health

Validation & Triangulation

  • Cross-validation of findings through multiple data sources, including sales data and market reports
  • Triangulation of insights from primary interviews with secondary research findings
  • Sanity checks conducted through expert panel reviews to ensure data accuracy

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total market size based on national veterinary expenditure and animal population statistics
  • Segmentation of the market by product categories such as pharmaceuticals, vaccines, and diagnostics
  • Incorporation of growth rates from historical data and projected trends in pet ownership and livestock farming

Bottom-up Modeling

  • Collection of sales data from leading animal health companies to establish baseline figures
  • Estimation of market share for various product segments based on firm-level performance
  • Volume and pricing analysis to derive revenue estimates for each segment

Forecasting & Scenario Analysis

  • Utilization of time-series analysis to project future market growth based on historical trends
  • Scenario modeling based on potential regulatory changes and shifts in consumer preferences
  • Development of best-case, worst-case, and most-likely scenarios through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Veterinary Pharmaceuticals120Veterinarians, Pharmacy Managers
Animal Vaccines100Veterinary Technicians, Animal Health Researchers
Pet Care Products120Pet Owners, Retail Managers
Livestock Health Solutions80Farm Managers, Livestock Veterinarians
Diagnostic Tools and Services90Laboratory Technicians, Veterinary Clinic Owners

Frequently Asked Questions

What is the current value of the US Animal Health Market?

The US Animal Health Market is valued at approximately USD 19 billion, reflecting significant growth driven by increased pet ownership, heightened awareness of animal health, and advancements in veterinary medicine.

What factors are driving growth in the US Animal Health Market?

Who are the major players in the US Animal Health Market?

What are the main segments of the US Animal Health Market?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022